• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为实现最佳清除效果:基于亲和力的通用质谱分析法,用于全面评估 ELISA 试剂覆盖度和 HCP 搭便车分析。

Toward optimal clearance: A universal affinity-based mass spectrometry approach for comprehensive ELISA reagent coverage evaluation and HCP hitchhiker analysis.

机构信息

Roche Diagnostics GmbH, Penzberg, Germany.

出版信息

Biotechnol Prog. 2022 May;38(3):e3244. doi: 10.1002/btpr.3244. Epub 2022 Mar 11.

DOI:10.1002/btpr.3244
PMID:35150475
Abstract

In the control strategy for process related impurities in biopharmaceuticals, the enzyme linked immunosorbent assay (ELISA) is the method of choice for the quantification of host cell proteins (HCPs). Besides two dimensional-western blots (2D-WB), the coverage of ELISA antibodies is increasingly evaluated by affinity purification-based liquid chromatography-tandem mass spectrometry (AP-MS) methods. However, all these methods face the problem of unspecific binding issues between antibodies and the matrix, involving the application of arbitrarily defined thresholds during data evaluation. To solve this, a new approach (optimized AP-MS) was developed in this study, for which a cleavable linker was conjugated to the ELISA antibodies enabling the subsequent isolation of specifically interacting HCPs. By comparing both approaches in terms of method variability and the number of false positive or negative hits, we could demonstrate that the optimized AP-MS method is very reproducible and superior in the identification of antibody detection gaps, while previously described strategies suffered from over- or underestimating the coverage. As only antibody associated HCPs were identified, we demonstrated that the method is beneficial for hitchhiker analysis. Overall, the method described herein has proven as a powerful tool for reliable coverage determination of ELISA antibodies, without the need to arbitrarily exclude HCPs during the coverage evaluation.

摘要

在与生物制药工艺相关杂质的控制策略中,酶联免疫吸附测定(ELISA)是定量宿主细胞蛋白(HCP)的首选方法。除了二维-免疫印迹(2D-WB),ELISA 抗体的覆盖范围也越来越多地通过基于亲和纯化的液相色谱-串联质谱(AP-MS)方法进行评估。然而,所有这些方法都面临着抗体和基质之间非特异性结合问题,在数据评估过程中涉及任意定义阈值的应用。为了解决这个问题,本研究开发了一种新方法(优化的 AP-MS),其中将可裂解的接头连接到 ELISA 抗体上,从而能够随后分离特异性相互作用的 HCP。通过比较两种方法在方法变异性和假阳性或假阴性命中数量方面的差异,我们可以证明优化的 AP-MS 方法非常具有重现性,并且在识别抗体检测差距方面具有优势,而以前描述的策略存在高估或低估覆盖范围的问题。由于仅鉴定了与抗体相关的 HCP,我们证明该方法有利于搭便车分析。总体而言,本文所述的方法已被证明是一种可靠的 ELISA 抗体覆盖范围确定的有力工具,而无需在覆盖范围评估过程中任意排除 HCP。

相似文献

1
Toward optimal clearance: A universal affinity-based mass spectrometry approach for comprehensive ELISA reagent coverage evaluation and HCP hitchhiker analysis.为实现最佳清除效果:基于亲和力的通用质谱分析法,用于全面评估 ELISA 试剂覆盖度和 HCP 搭便车分析。
Biotechnol Prog. 2022 May;38(3):e3244. doi: 10.1002/btpr.3244. Epub 2022 Mar 11.
2
A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.一种评估宿主细胞蛋白 ELISA 抗体覆盖度的新方法——结合 ELISA 免疫捕获和质谱法。
Biotechnol Prog. 2020 Jul;36(4):e2983. doi: 10.1002/btpr.2983. Epub 2020 Mar 9.
3
ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.采用亲和纯化串联质谱法评估 ELISA 试剂的覆盖度。
MAbs. 2017 Oct;9(7):1065-1075. doi: 10.1080/19420862.2017.1349586. Epub 2017 Jul 14.
4
Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.平台宿主细胞蛋白 ELISA 与工艺特异性宿主细胞蛋白 ELISA 的比较。
Biotechnol Bioeng. 2018 Feb;115(2):382-389. doi: 10.1002/bit.26466. Epub 2017 Oct 30.
5
Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.宿主细胞蛋白检测残留风险降低:用于 ELISA 抗体试剂覆盖率测定的定量 IAC-MS。
MAbs. 2021 Jan-Dec;13(1):1955432. doi: 10.1080/19420862.2021.1955432.
6
Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins.治疗性单克隆抗体下游处理中宿主细胞蛋白的深度分析综合策略:分离和消化宿主细胞蛋白的新方法。
Eur J Pharm Biopharm. 2024 Aug;201:114369. doi: 10.1016/j.ejpb.2024.114369. Epub 2024 Jun 15.
7
Identification of a host cell protein impurity in therapeutic protein, P1.治疗性蛋白质P1中宿主细胞蛋白杂质的鉴定
J Pharm Biomed Anal. 2017 Jul 15;141:32-38. doi: 10.1016/j.jpba.2017.03.065. Epub 2017 Apr 9.
8
Questioning coverage values determined by 2D western blots: A critical study on the characterization of anti-HCP ELISA reagents.质疑 2D 印迹法测定的覆盖率值:抗 HCP ELISA 试剂特性的关键研究。
Biotechnol Bioeng. 2021 Mar;118(3):1116-1126. doi: 10.1002/bit.27635. Epub 2020 Dec 4.
9
Monitoring process-related impurities in biologics-host cell protein analysis.监测生物制品-宿主细胞蛋白分析中的工艺相关杂质。
Anal Bioanal Chem. 2022 Jan;414(2):747-758. doi: 10.1007/s00216-021-03648-2. Epub 2021 Oct 1.
10
Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.鉴定和表征单克隆抗体纯化过程中共同纯化的 CHO 宿主细胞蛋白。
J Pharm Biomed Anal. 2019 Sep 10;174:500-508. doi: 10.1016/j.jpba.2019.06.021. Epub 2019 Jun 18.

引用本文的文献

1
Effect of Host Cell Protein on Chinese Hamster Ovary Recombinant Protein Production and its Removal Strategies: A Mini Review.宿主细胞蛋白对中国仓鼠卵巢重组蛋白生产的影响及其去除策略:小型综述。
Curr Pharm Biotechnol. 2024;25(6):665-675. doi: 10.2174/1389201024666230818112633.
2
Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development.基于 LC-MS/MS 的宿主细胞蛋白鉴定和定量方法的技术进展及实际考虑因素,以支持工艺开发。
MAbs. 2023 Jan-Dec;15(1):2213365. doi: 10.1080/19420862.2023.2213365.